Akhtar S, Zuhair F
Int J Nanomedicine. 2025; 20:2847-2878.
PMID: 40078651
PMC: 11899938.
DOI: 10.2147/IJN.S500978.
Seyfi M, Letafati A, Edalat F, Shatizadeh Malekshahi S, Pirbonyeh N, Moattari A
BMC Res Notes. 2025; 18(1):75.
PMID: 39966976
PMC: 11834247.
DOI: 10.1186/s13104-025-07143-0.
Perumalsamy H, Xiao X, Han H, Oh J, Yoon S, Heo M
J Nanobiotechnology. 2024; 22(1):765.
PMID: 39696498
PMC: 11657454.
DOI: 10.1186/s12951-024-03036-9.
Moulton C, Baroni A, Quagliarini E, Leone L, Digiacomo L, Morotti M
Front Immunol. 2024; 15:1447567.
PMID: 39600701
PMC: 11588692.
DOI: 10.3389/fimmu.2024.1447567.
Alhaddad R, Abualsoud B, Al-Deeb I, Nsairat H
Future Sci OA. 2024; 10(1):2419806.
PMID: 39539163
PMC: 11572278.
DOI: 10.1080/20565623.2024.2419806.
Exploring the green synthesis of silver nanoparticles using natural extracts and their potential for cancer treatment.
Abdellatif A, Mostafa M, Konno H, Younis M
3 Biotech. 2024; 14(11):274.
PMID: 39450421
PMC: 11496425.
DOI: 10.1007/s13205-024-04118-z.
Nanoparticle-neutrophils interactions for autoimmune regulation.
Kupor D, Felder M, Kodikalla S, Chu X, Eniola-Adefeso O
Adv Drug Deliv Rev. 2024; 209:115316.
PMID: 38663550
PMC: 11246615.
DOI: 10.1016/j.addr.2024.115316.
Metal nanoparticles for cancer therapy: Precision targeting of DNA damage.
Chen Q, Fang C, Xia F, Wang Q, Li F, Ling D
Acta Pharm Sin B. 2024; 14(3):1132-1149.
PMID: 38486992
PMC: 10934341.
DOI: 10.1016/j.apsb.2023.08.031.
Surface Geometry of Cargo-less Gold Nanoparticles Is a Driving Force for Selective Targeting of Activated Neutrophils to Reduce Thrombosis in Antiphospholipid Syndrome.
Di L, Thomas A, Switala L, Kalikasingh K, Lapping S, Nayak L
Nano Lett. 2023; 23(21):9690-9696.
PMID: 37884274
PMC: 10636870.
DOI: 10.1021/acs.nanolett.3c02075.
Metallic Nanoparticles and Core-Shell Nanosystems in the Treatment, Diagnosis, and Prevention of Parasitic Diseases.
Krol G, Fortunka K, Majchrzak M, Piktel E, Paprocka P, Mankowska A
Pathogens. 2023; 12(6).
PMID: 37375528
PMC: 10301874.
DOI: 10.3390/pathogens12060838.
Prospects for the Use of Metal-Based Nanoparticles as Adjuvants for Local Cancer Immunotherapy.
Naletova I, Tomasello B, Attanasio F, Pleshkan V
Pharmaceutics. 2023; 15(5).
PMID: 37242588
PMC: 10222518.
DOI: 10.3390/pharmaceutics15051346.
Development of Decellularized Fish Skin Scaffold Decorated with Biosynthesized Silver Nanoparticles for Accelerated Burn Wound Healing.
Adhikari S, Paudel A, Sharma A, Thapa B, Khanal N, Shastri N
Int J Biomater. 2023; 2023:8541621.
PMID: 36760230
PMC: 9904935.
DOI: 10.1155/2023/8541621.
Emerging applications of nanotechnology in context to immunology: A comprehensive review.
Mobeen H, Safdar M, Fatima A, Afzal S, Zaman H, Mehdi Z
Front Bioeng Biotechnol. 2023; 10:1024871.
PMID: 36619389
PMC: 9815620.
DOI: 10.3389/fbioe.2022.1024871.
The Impact of PEGylation on Cellular Uptake and In Vivo Biodistribution of Gold Nanoparticle MRI Contrast Agents.
El-Baz N, Nunn B, Bates P, OToole M
Bioengineering (Basel). 2022; 9(12).
PMID: 36550972
PMC: 9774698.
DOI: 10.3390/bioengineering9120766.
Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.
Lenders V, Koutsoumpou X, Sargsian A, Manshian B
Nanoscale Adv. 2022; 2(11):5046-5089.
PMID: 36132021
PMC: 9418019.
DOI: 10.1039/d0na00478b.
Nanoparticle Effects on Stress Response Pathways and Nanoparticle-Protein Interactions.
Cameron S, Sheng J, Hosseinian F, Willmore W
Int J Mol Sci. 2022; 23(14).
PMID: 35887304
PMC: 9323783.
DOI: 10.3390/ijms23147962.
Exploring near-infrared absorbing nanocarriers to overcome cancer drug resistance.
Chu S, Stochaj U
Cancer Drug Resist. 2022; 3(3):302-333.
PMID: 35582453
PMC: 8992494.
DOI: 10.20517/cdr.2020.20.
Iron oxide nanoparticle-induced hematopoietic and immunological response in rats.
Gaharwar U, Kumar S, Rajamani P
RSC Adv. 2022; 10(59):35753-35764.
PMID: 35517102
PMC: 9056920.
DOI: 10.1039/d0ra05901c.
Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.
Calatayud D, Neophytou S, Nicodemou E, Giuffrida S, Ge H, Pascu S
Front Chem. 2022; 10:830133.
PMID: 35494646
PMC: 9039169.
DOI: 10.3389/fchem.2022.830133.
Synthesis, Characterization, and Toxicological Evaluation of Copper (II) Oxide Containing Herbometallic Siddha Nanocomplex "Thamira Parpam".
Parthasarathy P, Manikandamathavan V, Chandronitha C, Vasanthi H, Mohan V, Vijayakumar V
Front Bioeng Biotechnol. 2022; 10:849441.
PMID: 35480968
PMC: 9037038.
DOI: 10.3389/fbioe.2022.849441.